Topics

Articles

US tax rules scuttle merger, while the US' second biosimilar wins FDA approval

Experience--mostly in Europe--indicates a heavy educational burden for patients and physicians

Partnership combines mail-order PBM with brick-and-mortar drugstores

Annual report highlights company's cost-control measures

New subsidiary of The Medical Affairs Co. hopes to fill gaps in CSO offerings

Discerning how and where products are discounted is an expensive headache for manufacturers

Managing partner at Numerof & Associates.

A new, market-driven model of drug development and commercialization is appearing*

Looking at 'cost' and 'value' under different evaluation processes

Quad-C investment will enable future acquisitions